Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Political Reporter Online.
Press releases published on May 23, 2025
MADD Canada réitère sa demande de sanctions administratives pour les taux d’alcoolémie de 0,05 % à 0,08 % au Québec
GlobeNewswire
·
May 23, 2025
MONTRÉAL, 23 mai 2025 (GLOBE NEWSWIRE) -- MADD Canada relance son appel au gouvernement du Québec pour qu'il mette en place des sanctions administratives pour les conducteurs dont le taux d'alcoolémie (TA) est entre 0,05 % et 0,08 %. Toutes les autres …
Transaction in Own Shares
GlobeNewswire
·
May 23, 2025
Transaction in Own Shares 23 May, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 23 May, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading …
Assystem: Combined General Meeting of 23 May 2025 - Voting results and dividend for financial year 2024
GlobeNewswire
·
May 23, 2025
Combined General Meeting of 23 May 2025 Voting results and dividend for financial year 2024 Paris-La Défense, on 23 May 2025, 6.00 p.m (CET) – Assystem S.A. (ISIN: FR0000074148 – ASY), confirms that its Combined General Meeting was held today, at the …
Assystem : Assemblée Générale Mixte du 23 mai 2025 - Résultat des votes et dividende au titre de l'exercice 2024
GlobeNewswire
·
May 23, 2025
Assemblée Générale Mixte du 23 mai 2025 Résultat des votes et dividende au titre de l’exercice 2024 Paris-La Défense, le 23 mai 2025, 18h00 – L’Assemblée Générale Mixte d’Assystem S.A.(ISIN : FR0000074148 – ASY) s’est réunie ce jour au centre de …
Combined General Meeting of June 13, 2025
GlobeNewswire
·
May 23, 2025
Combined General Meeting of June 13, 2025 Access to information Paris, France – May 23, 2025 – Atos SE shareholders are invited to attend the Combined General Meeting of the Company to be held on Friday, June 13, 2025 at 10 a.m. (Paris time) at the …
Assemblée Générale Mixte du 13 juin 2025
GlobeNewswire
·
May 23, 2025
Assemblée Générale Mixte du 13 juin 2025 Modalités de mise à disposition des documents préparatoires Paris, France – 23 mai 2025 – Les actionnaires d’Atos SE sont invités à participer à l’Assemblée Générale mixte de la Société qui se tiendra le vendredi 13 …
FRO - Q1 2025 Presentation
GlobeNewswire
·
May 23, 2025
Please find enclosed the presentation of Frontline plc´s first quarter 2025 results to be held on the webcast / conference call 23 May, 2025 at 15:00 CET. This information is subject to the disclosure requirements pursuant to section 5 – 12 of the …
LYB announces increase to quarterly dividend
GlobeNewswire
·
May 23, 2025
HOUSTON and LONDON, May 23, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB) today announced its board of directors has declared a quarterly dividend of $1.37 per share, representing a $0.03 per share increase over the company's first quarter 2025 …
Inventiva reports 2025 First Quarter Financial Information¹
GlobeNewswire
·
May 23, 2025
Cash and cash equivalents at €67.9 million Daix (France), New York City (New York, United States), May 23, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral …
Inventiva publie ses informations financières¹ du 1er trimestre 2025
GlobeNewswire
·
May 23, 2025
Trésorerie et équivalents de trésorerie à 67,9 millions d’euros Daix (France), New York City (New York, Etats-Unis), le 23 mai 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans …
EXEL Industries: 2024–2025 half-year results
GlobeNewswire
·
May 23, 2025
First half 2024–2025 results Priority given to reducing debt and optimizing WCR in the first half, positive net income driven by lower costs in response to lower volumes in Agricultural Spraying In the first half of 2024–2025, EXEL Industries's revenue …
EXEL Industries : résultats semestriels 2024–2025
GlobeNewswire
·
May 23, 2025
Résultats semestriels 2024–2025 Priorité à la réduction de la dette et l’optimisation du BFR au premier semestre, résultat net positif porté par la baisse des coûts en réaction à la baisse des volumes dans la Pulvérisation agricole Au premier semestre 2024 …
Results of the Votes of the Combined Shareholders’ General Meeting of May 22, 2025
GlobeNewswire
·
May 23, 2025
Daix (France), New York City (New York, United States), May 23, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic …
Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunies le 22 mai 2025
GlobeNewswire
·
May 23, 2025
Daix (France), New York City (New York, Etats-Unis), le 23 mai 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de thérapies orales pour le traitement de la …
Endeavour Announces Results of Annual General Meeting 2025
GlobeNewswire
·
May 23, 2025
ENDEAVOUR ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING 2025 London, 23 May 2025 – Endeavour Mining plc (LSE:EDV, TSX:EDV, OTCQX:EDVMF) (“the Company”) is pleased to announce that all resolutions at yesterday's annual general meeting (“AGM”) were duly passed …
FRO – First Quarter 2025 Results
GlobeNewswire
·
May 23, 2025
FRONTLINE PLC REPORTS RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2025 Frontline plc (the “Company”, “Frontline,” “we,” “us,” or “our”), today reported unaudited results for the three months ended March 31, 2025: Highlights Profit of $33.3 million, or $ …
OSE Immunotherapeutics Announces that its Partner Boehringer Ingelheim Will Present Early Clinical Evidence of Innate Immune Modulation and Anti-Tumor Activity via SIRPα Blockade in Two Ongoing Trials at ASCO 2025
GlobeNewswire
·
May 23, 2025
OSE Immunotherapeutics Announces that its Partner Boehringer Ingelheim Will Present Early Clinical Evidence of Innate Immune Modulation and Anti-Tumor Activity via SIRPα Blockade in Two Ongoing Trials at ASCO 2025 BI 765063 in combination with programmed …
OSE Immunotherapeutics annonce que son partenaire Boehringer Ingelheim présentera des premières données cliniques issues de deux essais en cours
GlobeNewswire
·
May 23, 2025
OSE Immunotherapeutics annonce que son partenaire Boehringer Ingelheim présentera des premières données cliniques issues de deux essais en cours sur la modulation de l’immunité innée et l’activité antitumorale via le blocage de SIRPα à l’ASCO 2025 BI …
De Havilland Canada announces the expansion of its presence in Greece
GlobeNewswire
·
May 23, 2025
ATHENS, Greece, May 23, 2025 (GLOBE NEWSWIRE) -- De Havilland Aircraft of Canada Limited (“De Havilland Canada”) is pleased to announce the launch of De Havilland Aircraft of Canada Hellas Ltd., its new wholly-owned subsidiary in Greece, further …